Procalcitonin as a marker of sepsis.

PubWeight™: 1.52‹?› | Rank: Top 4%

🔗 View Article (PMID 12127705)

Published in Int J Antimicrob Agents on July 01, 2002

Authors

E D Carrol1, A P J Thomson, C A Hart

Author Affiliations

1: Institute of Child Health, Royal Liverpool Children's Hospital NHS Trust, Alder Hey, Eaton Road, Liverpool L12 2AP, UK. edcarrol@liv.ac.uk

Articles citing this

Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis. Crit Care (2013) 1.88

Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care (2002) 1.55

Predictive value of procalcitonin for the diagnosis of bowel strangulation. World J Surg (2005) 1.51

Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis (2006) 1.18

Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome. Arch Dis Child (2005) 1.13

A prospective bicenter study investigating the diagnostic value of procalcitonin in patients with acute appendicitis. Eur Surg Res (2009) 1.02

Procalcitonin: a reliable marker for the diagnosis of neonatal sepsis. Iran J Basic Med Sci (2012) 0.96

Biomarkers for diagnosis of neonatal infections: A systematic analysis of their potential as a point-of-care diagnostics. J Glob Health (2011) 0.93

Analysis of procalcitonin and CRP concentrations in serum of patients with chronic spontaneous urticaria. Inflamm Res (2012) 0.92

Procalcitonin and quantitative C-reactive protein role in the early diagnosis of sepsis in patients with febrile neutropenia. South Asian J Cancer (2013) 0.92

Novel biomarkers to detect infection in revision hip and knee arthroplasties. Clin Orthop Relat Res (2013) 0.91

A study on biomarkers, cytokines, and growth factors in children with burn injuries. Ann Burns Fire Disasters (2007) 0.89

Pre-emptive antibiotic treatment vs 'standard' treatment in patients with elevated serum procalcitonin levels after elective colorectal surgery: a prospective randomised pilot study. Langenbecks Arch Surg (2005) 0.89

Lipocalin 2 in cerebrospinal fluid as a marker of acute bacterial meningitis. BMC Infect Dis (2014) 0.88

Comparison between procalcitonin and C-reactive protein for early diagnosis of children with sepsis or septic shock. Inflamm Res (2010) 0.88

Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis. Langenbecks Arch Surg (2004) 0.86

Can serum procalcitonin and C-reactive protein as nosocomial infection markers in hospitalized patients without localizing signs? J Res Med Sci (2011) 0.84

Procalcitonin Identifies Cell Injury, Not Bacterial Infection, in Acute Liver Failure. PLoS One (2015) 0.82

Diagnostic value of procalcitonin for acute complicated appendicitis. Nagoya J Med Sci (2016) 0.81

Elevated procalcitonin as a diagnostic marker in meningococcal disease. Eur J Clin Microbiol Infect Dis (2006) 0.81

Procalcitonin as the biomarker of inflammation in diagnosis of appendicitis in pediatric patients and prevention of unnecessary appendectomies. Indian J Surg (2010) 0.80

Circulating cytokines and procalcitonin in acute Q fever granulomatous hepatitis with poor response to antibiotic and short-course steroid therapy: a case report. BMC Infect Dis (2010) 0.80

Cardiorenal biomarkers in acute heart failure. J Geriatr Cardiol (2012) 0.78

Utility of cytokine, adhesion molecule and acute phase proteins in early diagnosis of neonatal sepsis. J Nat Sci Biol Med (2017) 0.77

Factors which affect mortality in neonatal sepsis. Turk Pediatri Ars (2015) 0.75

Evaluation of diagnostic value of procalcitonin as a marker of neonatal bacterial infections. Iran J Pediatr (2012) 0.75

Diagnostic Value of Procalcitonin Levels in Acute Mesenteric Ischemia. Balkan Med J (2015) 0.75

Determining the Clinical Utility of an Absolute Procalcitonin Value for Predicting a Positive Culture Result. Antimicrob Agents Chemother (2017) 0.75

Articles by these authors

Reproductive tract infections and abortion among adolescent girls in rural Nigeria. Lancet (1995) 4.86

Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet (1996) 4.07

Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa. Lancet (2001) 3.49

Validation of the Glasgow Meningococcal Septicemia Prognostic Score: a 10-year retrospective survey. Crit Care Med (1991) 3.29

Antibiotic resistance found in wild rodents. Nature (1999) 3.20

Mortality in severe meningococcal disease. Arch Dis Child (2001) 3.03

Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol (2003) 2.56

Molecular characterization of a novel plasmid-encoded cefotaximase (CTX-M-12) found in clinical Klebsiella pneumoniae isolates from Kenya. Antimicrob Agents Chemother (2001) 2.39

Rotavirus G and P types in children with acute diarrhea in Blantyre, Malawi, from 1997 to 1998: predominance of novel P[6]G8 strains. J Med Virol (1999) 2.33

Nontyphoidal Salmonella infections of children in tropical Africa. Pediatr Infect Dis J (2000) 2.32

Clinical presentation and outcome of Pneumocystis carinii pneumonia in Malawian children. Lancet (2000) 2.28

Vulvovaginitis: causes and management. Arch Dis Child (1992) 2.28

Who spots the spots? Diagnosis and treatment of early meningococcal disease in children. BMJ (1996) 2.20

Human cryptosporidiosis: a possible case of hospital cross infection. Br Med J (Clin Res Ed) (1983) 2.02

Updating the nurse's bedside manner. Image J Nurs Sch (1993) 2.02

Antibiotic resistance: an increasing problem?. It always has been, but there are things we can do. BMJ (1998) 2.00

Platelet-derived growth factor-modulated proteins: constitutive synthesis by a transformed cell line. Proc Natl Acad Sci U S A (1981) 1.90

Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control. Trop Med Int Health (1999) 1.90

Human herpesviruses in the cornea. Br J Ophthalmol (2000) 1.90

Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival. Blood (1998) 1.89

Hantaviruses. J Med Microbiol (2000) 1.86

The prevalence of enteric pathogens in diarrhoeic thoroughbred foals in Britain and Ireland. Equine Vet J (1991) 1.76

Genotype analysis of Escherichia coli strains isolated from children and chickens living in close contact. Appl Environ Microbiol (1999) 1.73

The development and performance of a simple, sensitive method for the detection of Cryptosporidium oocysts in faeces. J Hyg (Lond) (1984) 1.73

Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization. Bull World Health Organ (1998) 1.72

Severe hypophosphatemia in children with kwashiorkor is associated with increased mortality. J Pediatr (1998) 1.70

Isolation from Klebsiella and characterization of two rcs genes that activate colanic acid capsular biosynthesis in Escherichia coli. J Gen Microbiol (1987) 1.70

Procalcitonin as a diagnostic marker of meningococcal disease in children presenting with fever and a rash. Arch Dis Child (2002) 1.69

Rotavirus strain diversity in Blantyre, Malawi, from 1997 to 1999. J Clin Microbiol (2001) 1.68

Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children. Lancet (2001) 1.67

Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. J Infect (2008) 1.66

Features and outcome in meningococcal disease presenting with maculopapular rash. Arch Dis Child (1991) 1.65

Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Arch Dis Child (1995) 1.65

Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch Dis Child (2002) 1.64

Multi-drug resistant typhoid: a global problem. J Med Microbiol (1996) 1.64

Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. J Infect Dis (1996) 1.63

Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax (2004) 1.62

Particles with properties of retroviruses in monocytes from patients with breast cancer. Lancet (1988) 1.62

Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer (1998) 1.61

Bovine digital dermatitis and severe virulent ovine foot rot: a common spirochaetal pathogenesis. Vet J (2005) 1.59

Molecular epidemiology of rotavirus diarrhea among children and adults in Nepal: detection of G12 strains with P[6] or P[8] and a G11P[25] strain. J Clin Microbiol (2006) 1.51

Prophylactic treatment of anthrax with antibiotics. BMJ (2001) 1.51

Antibody to streptococcal cell wall peptidoglycan-polysaccharide polymers in seropositive and seronegative rheumatic disease. Clin Exp Immunol (1984) 1.50

Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax (1998) 1.50

Analysis of plasmid and chromosomal DNA of multidrug-resistant Salmonella enterica serovar typhi from Asia. J Clin Microbiol (2000) 1.49

Pulsed-field gel electrophoresis of degradation-sensitive DNAs from Clostridium difficile PCR ribotype 1 strains. J Clin Microbiol (2000) 1.48

Nitric oxide production in meningococcal disease is directly related to disease severity. Crit Care Med (1999) 1.47

Selective decontamination of the digestive tract (SDD) in intensive care patients: a critical evaluation of the clinical, bacteriological and epidemiological benefits. J Hosp Infect (1991) 1.46

Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces. J Hosp Infect (2005) 1.46

Is Mycoplasma hominis a vaginal pathogen? Sex Transm Infect (2001) 1.46

Severe meningococcal disease in childhood. Br J Anaesth (2003) 1.45

The use of sputum induction for establishing a diagnosis in patients with suspected pulmonary tuberculosis in Malawi. Tuber Lung Dis (1995) 1.45

Hypocalcaemia in severe meningococcal infections. Arch Dis Child (2000) 1.45

Gastro-enteritis due to Cryptosporidium: a prospective survey in a children's hospital. J Infect (1984) 1.43

Sputum induction for the diagnosis of tuberculosis. Arch Dis Child (1996) 1.43

Frequency and spatial distribution of environmental Campylobacter spp. Appl Environ Microbiol (2004) 1.42

Hepatitis G virus infection in drug users in Liverpool. J Infect (1998) 1.41

Plasma fibronectin levels in meningococcal disease. Eur J Pediatr (1997) 1.40

Diagnosis of pulmonary tuberculosis in children in an HIV-endemic area, Malawi. Ann Trop Paediatr (2001) 1.39

Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives. Thorax (2002) 1.39

Ecdysone agonist inducible transcription in transgenic tobacco plants. Plant J (1999) 1.38

Resistance to cephalosporins among gentamicin-resistant klebsiellae. J Antimicrob Chemother (1982) 1.38

Identification of epitopes recognized by monoclonal antibodies SM1 and SM2 which react with all pili of Neisseria gonorrhoeae but which differentiate between two structural classes of pili expressed by Neisseria meningitidis and the distribution of their encoding sequences in the genomes of Neisseria spp. J Gen Microbiol (1989) 1.38

Seroprevalence of hepatitis B and C and HIV in Malawian pregnant women. J Infect (1998) 1.37

Presence of type III secretion genes in Burkholderia pseudomallei correlates with Ara(-) phenotypes. J Clin Microbiol (2000) 1.36

The incidence of cryptosporidiosis: a two-year prospective survey in a children's hospital. J Hyg (Lond) (1986) 1.36

Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Arch Dis Child (2003) 1.36

Variation in serum C-reactive protein across the clinical spectrum of meningococcal disease. Acta Paediatr (1993) 1.36

Reduced transfer of tetanus antibodies with placental malaria. Lancet (1994) 1.35

Increased faecal mucin sulphatase activity in ulcerative colitis: a potential target for treatment. Gut (1995) 1.34

Fluoroquinolones: place in ocular therapy. Drugs (2001) 1.34

Intermittent and persistent shedding of Escherichia coli O157 in cohorts of naturally infected calves. J Appl Microbiol (2004) 1.33

Evidence for the presence in Burkholderia pseudomallei of a type III secretion system-associated gene cluster. J Med Microbiol (1999) 1.31

The changing presentations of meningococcal disease. Eur J Pediatr (1995) 1.31

Performance characteristics of the polymerase chain reaction assay to confirm clinical meningococcal disease. Arch Dis Child (2000) 1.30

Type III secretion systems and pathogenicity islands. J Med Microbiol (2001) 1.30

Mycobacterium microti infection (vole tuberculosis) in wild rodent populations. J Clin Microbiol (2002) 1.30

Klebsiellae and neonates. J Hosp Infect (1993) 1.28

Placental antibody transfer: influence of maternal HIV infection and placental malaria. Arch Dis Child Fetal Neonatal Ed (1998) 1.27

Shedding of oocysts by immunocompetent individuals with cryptosporidiosis. J Hyg (Lond) (1985) 1.27

Clinical predictors of hypoxaemia in children with pneumonia. Ann Trop Paediatr (1998) 1.27

Evidence for herpes simplex viral latency in the human cornea. Br J Ophthalmol (1991) 1.27

High-titre anti-CMV plasma in treatment of neonatal cytomegalovirus infection. Lancet (1984) 1.24

A novel mucin sulphatase from human faeces: its identification, purification and characterization. Clin Sci (Lond) (1992) 1.23

Expanding global distribution of rotavirus serotype G9: detection in Libya, Kenya, and Cuba. Emerg Infect Dis (2001) 1.23

Diarrhoea due to Cryptosporidium in acute lymphoblastic leukemia. Arch Dis Child (1985) 1.22

Flagellin gene and protein variation amongst clinical isolates of Pseudomonas aeruginosa. Microbiology (1996) 1.21

Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs. Br J Cancer (2006) 1.21

Genotypic analysis of multidrug-resistant Salmonella enterica Serovar typhi, Kenya. Emerg Infect Dis (2001) 1.21

Multi-drug resistant non-typhi salmonellae in Kenya. J Antimicrob Chemother (1996) 1.21

Serious infection in a neonatal intensive care unit: a two-year survey. J Hyg (Lond) (1985) 1.20

Contribution of capsular polysaccharide and surface properties to virulence of Escherichia coli K1. Infect Immun (1987) 1.19

Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan. Pediatr Infect Dis J (1995) 1.18

Reproductive tract infections, gynaecological morbidity and HIV seroprevalence among women in Mumbai, India. Bull World Health Organ (1998) 1.16

Molecular and serologic characterization of novel serotype G8 human rotavirus strains detected in Blantyre, Malawi. Virology (2000) 1.14

A comparison of the in-vitro activity of antimicrobials against Chlamydia trachomatis examined by Giemsa and a fluorescent antibody stain. J Antimicrob Chemother (1985) 1.14

Variation in flagellin genes and proteins of Burkholderia cepacia. J Bacteriol (1998) 1.13

Evaluation of ciprofloxacin 500 mg twice daily for one week in treating uncomplicated gonococcal chlamydial, and non-specific urethritis in men. Genitourin Med (1986) 1.13